Quarterly report · Q1

Period2022-01-21 → 2022-04-20
Filed2022-06-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥34.8bn2022-01-21 → 2022-04-20Cons.Net sales
Revenue¥162.6bn2021-01-21 → 2022-01-20Cons.Net sales (5-year summary)
Revenue¥36.1bn2021-01-21 → 2021-04-20Cons.Net sales
Operating income−¥692m2022-01-21 → 2022-04-20Cons.Operating income
Operating income¥426m2021-01-21 → 2021-04-20Cons.Operating income
Ordinary income−¥585m2022-01-21 → 2022-04-20Cons.Ordinary income
Ordinary income¥5.7bn2021-01-21 → 2022-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥400m2021-01-21 → 2021-04-20Cons.Ordinary income
Profit before tax−¥676m2022-01-21 → 2022-04-20Cons.Income before income taxes
Profit before tax¥431m2021-01-21 → 2021-04-20Cons.Income before income taxes
Net income (owners)−¥857m2022-01-21 → 2022-04-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2021-01-21 → 2022-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥229m2021-01-21 → 2021-04-20Cons.Profit loss attributable to owners of parent
Net income−¥860m2022-01-21 → 2022-04-20Cons.Profit loss
Net income¥217m2021-01-21 → 2021-04-20Cons.Profit loss
Total assets¥163.8bnat 2022-04-20Cons.Assets
Total assets¥159.0bnat 2022-01-20Cons.Assets
Total assets¥163.5bnat 2021-04-20Cons.Total assets (5-year summary)
Total liabilities¥82.1bnat 2022-04-20Cons.Liabilities
Total liabilities¥75.7bnat 2022-01-20Cons.Liabilities
Net assets / equity¥81.7bnat 2022-04-20Cons.Net assets
Net assets / equity¥83.3bnat 2022-01-20Cons.Net assets
Net assets / equity¥83.8bnat 2021-04-20Cons.Net assets (5-year summary)
Cash and deposits¥27.4bnat 2022-04-20Cons.Cash and deposits
Cash and deposits¥27.6bnat 2022-01-20Cons.Cash and deposits
EPS (basic)¥-54.782022-01-21 → 2022-04-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥254.22021-01-21 → 2022-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.722021-01-21 → 2021-04-20Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.6%at 2022-04-20Cons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2022-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-04-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-04-20−¥134m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-04-20−¥134m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-04-20−¥270m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥24.8bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥24.8bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥12m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥325m
jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-04-20−¥96m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥1m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-04-20¥234m
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥3.0bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥3.0bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥205m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥2.9bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥2.7bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥120m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥28m
—segment totalrevenue2022-01-21 → 2022-04-20¥34.9bn
—segment totalrevenue external2022-01-21 → 2022-04-20¥34.8bn
—segment totalrevenue intersegment2022-01-21 → 2022-04-20¥134m
—segment totalsegment profit2022-01-21 → 2022-04-20−¥422m
Reconciling Itemsreconcilingrevenue2021-01-21 → 2021-04-20−¥126m
Reconciling Itemsreconcilingrevenue intersegment2021-01-21 → 2021-04-20−¥126m
Reconciling Itemsreconcilingsegment profit2021-01-21 → 2021-04-20−¥367m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥26.9bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥26.9bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥15m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥707m
jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segmentsegment profit2021-01-21 → 2021-04-20−¥44m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥1m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥143m
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥2.4bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥2.4bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-04-20−¥30m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥2.7bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥2.6bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥109m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥17m
—segment totalrevenue2021-01-21 → 2021-04-20¥36.3bn
—segment totalrevenue external2021-01-21 → 2021-04-20¥36.1bn
—segment totalrevenue intersegment2021-01-21 → 2021-04-20¥126m
—segment totalsegment profit2021-01-21 → 2021-04-20¥793m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
Loss on disaster elCurrentYTDDuration59000000JPY
Loss on liquidation of subsidiaries and affiliates general elPrior1YTDDuration-JPY
Loss on liquidation of subsidiaries and affiliates general elCurrentYTDDuration31000000JPY
Extraordinary lossPrior1YTDDuration18000000JPY
Extraordinary lossCurrentYTDDuration90000000JPY
Income before income taxesPrior1YTDDuration431000000JPY
Income before income taxesCurrentYTDDuration-676000000JPY
Income taxesPrior1YTDDuration213000000JPY
Income taxesCurrentYTDDuration184000000JPY
Profit lossPrior1YTDDuration217000000JPY
Profit lossCurrentYTDDuration-860000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-12000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration229000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-857000000JPY
Profit lossPrior1YTDDuration217000000JPY
Profit lossCurrentYTDDuration-860000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration2639000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-89000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration236000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration208000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration-246000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-463000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-13000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-61000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration0JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration0JPY
Other comprehensive incomePrior1YTDDuration2616000000JPY
Other comprehensive incomeCurrentYTDDuration-405000000JPY
Comprehensive incomePrior1YTDDuration2834000000JPY
Comprehensive incomeCurrentYTDDuration-1266000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration2874000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-1264000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-40000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-1000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember26907000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember2366000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember2584000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember4291000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember-JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember36150000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration36150000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember15000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember109000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember126000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-126000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-01-20pass rounding
balance sheet identityconsolidated 2022-04-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-01-20pass
statement vs summary · net assetsconsolidated 2022-04-20pass
statement vs summary · net income attributable to parentconsolidated 2021-01-21/2021-04-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-04-20pass
statement vs summary · revenueconsolidated 2021-01-21/2021-04-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-04-20pass
statement vs summary · total assetsconsolidated 2022-01-20pass
statement vs summary · total assetsconsolidated 2022-04-20pass